ATCC Wins Multimillion Dollar Contract to Manage and Operate One of the World’s Largest Repositories of Biological Specimens
Program adds to ATCC’s growing portfolio of biorepository management services
FOR IMMEDIATE RELEASE – Manassas, VA, October 11, 2016 – Leidos Biomedical Research, Inc. (Leidos Biomed) awarded ATCC, a global leader in biological materials management and standards, a two-year base option subcontract to manage and operate one of the largest repositories of biological specimens in the world, in Frederick, Md. The subcontract is valued up to $32 million over a seven-year period if all options are executed. This award will be fully funded under the Leidos Biomed prime contract HHSN261200800001E with the National Cancer Institute, National Institutes of Health
Under this subcontract, ATCC will receive, store, and distribute biospecimens to basic and clinical investigators supporting cancer and infectious disease research, as well as manage operational logistics and costs.
“ATCC is a world-recognized biological resource center with over 90 years of successful biorepository expertise,” said Dr. Raymond H. Cypess, ATCC Chairman and CEO. “We are honored to support Leidos Biomed and the National Cancer Institute in their important mission of supporting the biomedical community with advancements in cancer and infectious disease research. This program extends ATCC’s clinical biorepository management portfolio for both government and commercial customers.”
The NCI at Frederick Central Repository is part of the Frederick National Laboratory for Cancer Research, a federal national laboratory sponsored by NCI and operated under contract by Leidos Biomed.
The NCI at Frederick Central Repository is one of the largest repositories in the world with an inventory of more than 15 million clinical specimens. It serves as a national resource for the biomedical community by providing biospecimen collection management to the NCI and other government organizations.
ATCC is a leader in biological materials management, providing the worldwide scientific community and U.S. government with research and development, products, and services in support of global health issues. With a history of innovation spanning more than 90 years, ATCC offers the world’s largest and most diverse collection of human and animal cell lines, microorganisms, biological products, and standards. ATCC is a non-profit organization with headquarters in Manassas, VA, and an R&D and services center in Gaithersburg, MD.